Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury.
D000818:Animals; D007511:Ischemia; D007546:Isoquinolines / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology*; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D008297:Male; D008871:Microvilli / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D008933:Mitochondrial Swelling; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000517:prevention & control*; D044005:Tetrahydroisoquinolines; D013997:Time Factors
D007546:Isoquinolines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; C067430:TCV 309